These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Propionate catabolism by CD-associated adherent-invasive Agus A; Richard D; Faïs T; Vazeille E; Chervy M; Bonnin V; Dalmasso G; Denizot J; Billard E; Bonnet R; Buisson A; Barnich N; Delmas J Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33769191 [TBL] [Abstract][Full Text] [Related]
8. The role of Escherichia coli in inflammatory bowel disease. Rhodes JM Gut; 2007 May; 56(5):610-2. PubMed ID: 17440180 [TBL] [Abstract][Full Text] [Related]
9. Enterovirulent E. coli in inflammatory and noninflammatory bowel diseases. Curová K; Kmetová M; Sabol M; Gombosová L; Lazúrová I; Siegfried L Folia Microbiol (Praha); 2009; 54(1):81-6. PubMed ID: 19330549 [TBL] [Abstract][Full Text] [Related]
10. Adherent-invasive Escherichia coli (AIEC): Cause or consequence of inflammation, dysbiosis, and rupture of cellular joints in patients with IBD? Perna A; Hay E; Contieri M; De Luca A; Guerra G; Lucariello A J Cell Physiol; 2020 Jun; 235(6):5041-5049. PubMed ID: 31898324 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis. Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121 [TBL] [Abstract][Full Text] [Related]
12. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. Yu LC J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiota, inflammatory bowel disease and colorectal cancer. Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114 [TBL] [Abstract][Full Text] [Related]
15. Professor Arlette Darfeuille-Michaud: the discovery of adherent-invasive Escherichia coli. Yang Y; Jobin C J Crohns Colitis; 2015 May; 9(5):373-5. PubMed ID: 25759068 [No Abstract] [Full Text] [Related]
16. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Baldelli V; Scaldaferri F; Putignani L; Del Chierico F Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33801755 [TBL] [Abstract][Full Text] [Related]
17. Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis. Hoffman LR; Pope CE; Hayden HS; Heltshe S; Levy R; McNamara S; Jacobs MA; Rohmer L; Radey M; Ramsey BW; Brittnacher MJ; Borenstein E; Miller SI Clin Infect Dis; 2014 Feb; 58(3):396-9. PubMed ID: 24178246 [TBL] [Abstract][Full Text] [Related]
18. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases. Tomasello G; Mazzola M; Leone A; Sinagra E; Zummo G; Farina F; Damiani P; Cappello F; Gerges Geagea A; Jurjus A; Bou Assi T; Messina M; Carini F Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):461-466. PubMed ID: 27812084 [TBL] [Abstract][Full Text] [Related]
19. [Enteric microflora in inflammatory bowel disease patients]. Rahmouni O; Dubuquoy L; Desreumaux P; Neut C Med Sci (Paris); 2016 Nov; 32(11):968-973. PubMed ID: 28008837 [TBL] [Abstract][Full Text] [Related]
20. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes. Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]